TrialEuropean journal of haematology2015

An open-label phase I/II study of cyclophosphamide, bortezomib, pegylated liposomal doxorubicin, and dexamethasone in newly diagnosed myeloma.

Taiga Nishihori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.